Human neutrophils in auto-immunity

Seminars in Immunology

Volumn 28, Issue 2, 2016, Pages 159-173

  Thieblemont, Nathalie ^a,b,c   Wright, Helen L ^d   Edwards, Steven W ^d   Witko Sarsat, Véronique ^a,b,c  

^a INSTITUT COCHIN   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c LABEX Inflamex   (France)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Apoptosis; Lupus; Neutrophils; Phagocytosis; Rheumatoid arthritis; Vasculitis

Indexed keywords

AUTOANTIBODY; AZUROCIDIN; BCL2 RELATED PROTEIN A1; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CATHEPSIN G; CYCLINE; ELASTASE; GELATINASE; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 6; LEUKOCYTE ELASTASE; LIPOCALIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL COLLAGENASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN ARGININE DEIMINASE; PROTEINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RIBONUCLEOPROTEIN; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; AUTOANTIGEN;

ADAPTIVE IMMUNITY; ANCA ASSOCIATED VASCULITIS; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ATHEROSCLEROSIS; AUTOIMMUNITY; BEHCET DISEASE; CELL NUCLEUS MEMBRANE; CHROMATIN STRUCTURE; CHRONIC GRANULOMATOUS DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEGRANULATION; DENDRITIC CELL; DNA SYNTHESIS; EOSINOPHILIC GRANULOMA; EXTRACELLULAR TRAP; GENE EXPRESSION; GENOME-WIDE ASSOCIATION STUDY; GLOMERULONEPHRITIS; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN CELL; IMMUNE DYSREGULATION; IMMUNOGLOBULIN PRODUCTION; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; JUVENILE RHEUMATOID ARTHRITIS; LEUKOCYTE ACTIVATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MACROPHAGE; MICROSCOPIC POLYANGIITIS; MONOCYTE; MULTIPLE SCLEROSIS; NEUTROPHIL; NEUTROPHIL GRANULE; PATHOGENESIS; PHAGOCYTE; PHAGOCYTOSIS; PLASMACYTOID DENDRITIC CELL; POLARIZATION; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; WEGENER GRANULOMATOSIS; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ADAPTIVE IMMUNITY; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; APOPTOSIS; ARTHRITIS, RHEUMATOID; AUTOANTIGENS; AUTOIMMUNITY; EXTRACELLULAR TRAPS; HUMANS; IMMUNITY, INNATE; LUPUS ERYTHEMATOSUS, SYSTEMIC; NEUTROPHIL ACTIVATION; NEUTROPHILS; PHAGOCYTOSIS;

EID: 84962328717     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2016.03.004     Document Type: Review

References (248)

1. Nauseef W.M., Borregaard N. Neutrophils at work. Nat. Immunol. 2014, 15:602-611.
2. Klebanoff S.J., Kettle A.J., Rosen H., Winterbourn C.C., Nauseef W.M. Myeloperoxidase a front-line defender against phagocytosed microorganisms. J. Leukoc. Biol. 2013, 93:185-198.
3. Roos D., van Bruggen R., Meischl C. Oxidative killing of microbes by neutrophils. Microbes Infect. 2003, 5:1307-1315.
4. Winterbourn C.C., Kettle A.J. Redox reactions and microbial killing in the neutrophil phagosome. Antioxididant Redox Signall. 2013, 18:642-660.
5. Hallett M.B., Lloyds D. Neutrophil priming: the cellular signals that say 'amber' but not 'green'. Immunol. Today 1995, 16:264-268.
6. Wright H.L., Moots R.J., Bucknall R.C., Edwards S.W. Neutrophil function in inflammation and inflammatory diseases. Rheumatology 2010, 49:1618-1631.
7. Wright H.L., Thomas H.B., Moots R.J., Edwards S.W. RNA-seq reveals activation of both common and cytokine-specific pathways following neutrophil priming. PLoS One 2013, 8:e58598.
8. Mantovani A., Cassatella M.A., Costantini C., Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 2011, 11:519-531.
9. Mayadas T.N., Cullere X., Lowell C.A. The multifaceted functions of neutrophils. Annu. Rev. Pathol. 2014, 9:181-218.
10. Wright H.L., Moots R.J., Edwards S.W. The multifactorial role of neutrophils in rheumatoid arthritis. Nat. Rev. Rheumatol. 2014, 10:593-601.
11. Jennette J.C., Falk R.J. Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat. Rev. Rheumatol. 2014, 10:463-473.
12. Stockley R.A. Neutrophils and the pathogenesis of COPD. Chest 2002, 121:151S-155S.
13. Fournier B.M., Parkos C.A. The role of neutrophils during intestinal inflammation. Mucosal Immunol. 2012, 5:354-366.
14. Fossati G., Bucknall R.C., Edwards S.W. Insoluble and soluble immune complexes activate neutrophils by distinct activation mechanisms: changes in functional responses induced by priming with cytokines. Ann. Rheum. Dis. 2002, 61:13-19.
15. Edwards S.W., Hughes V., Barlow J., Bucknall R. Immunological detection of myeloperoxidase in synovial fluid from patients with rheumatoid arthritis. Biochem. J. 1988, 250:81-85.
16. Weiss S.J. Tissue destruction by neutrophils. New Engl. J. Med. 1989, 320:365-376.
17. Mocsai A. Diverse novel functions of neutrophils in immunity, inflammation, and beyond. J. Exp. Med. 2013, 210:1283-1299.
18. McInnes I.B., Buckley C.D., Isaacs J.D. Cytokines in rheumatoid arthritis-shaping the immunological landscape. Nat. Rev. Rheumatol. 2016, 12:63-68.
19. Wright H.L., Bucknall R.C., Moots R.J., Edwards S.W. Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy. Rheumatology 2012, 51:451-459.
20. Burmester G.R., Feist E., Dorner T. Emerging cell and cytokine targets in rheumatoid arthritis. Nat. Rev. Rheumatol. 2014, 10:77-88.
21. Nemeth T., Mocsai A. The role of neutrophils in autoimmune diseases. Immunol. Lett. 2012, 143:9-19.
22. Rasheed Z. Hydroxyl radical damaged immunoglobulin G in patients with rheumatoid arthritis: biochemical and immunological studies. Clin. Biochem. 2008, 41:663-669.
23. Pillinger M.H., Abramson S.B. The neutrophil in rheumatoid arthritis. Rheum. Dis. Clin. North Am. 1995, 21:691-714.
24. Edwards S.W., Watson F., Gasmi L., Moulding D.A., Quayle J.A. Activation of human neutrophils by soluble immune complexes: role of Fc gamma RII and Fc gamma RIIIb in stimulation of the respiratory burst and elevation of intracellular Ca2+. Ann. N. Y. Acad. Sci. 1997, 832:341-357.
25. Witko-Sarsat V., Lesavre P., Lopez S., Bessou G., Hieblot C., Prum B., et al. A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. J. Am. Soc. Nephrol. 1999, 10:1224-1233.
26. Witko-Sarsat V., Pederzoli-Ribeil M., Hirsch E., Sozzani S., Cassatella M.A. Regulating neutrophil apoptosis: new players enter the game. Trends Immunol. 2011, 32:117-124.
27. McCracken J.M., Allen L.A. Regulation of human neutrophil apoptosis and lifespan in health and disease. J. Cell Death 2014, 7:15-23.
28. Kobayashi S.D., Voyich J.M., Braughton K.R., DeLeo F.R. Down-regulation of proinflammatory capacity during apoptosis in human polymorphonuclear leukocytes. J. Immunol. 2003, 170:3357-3368.
29. Sabroe I., Jones E.C., Usher L.R., Whyte M.K., Dower S.K. Toll-like receptor (TLR) 2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J. Immunol. 2002, 168:4701-4710.
30. Sabroe I., Prince L.R., Dower S.K., Walmsley S.R., Chilvers E.R., Whyte M.K. What can we learn from highly purified neutrophils. Biochem. Soc. Trans. 2004, 32:468-469.
31. Tak T., Tesselaar K., Pillay J., Borghans J.A., Koenderman L. What's your age again? Determination of human neutrophil half-lives revisited. J. Leukoc. Biol. 2013, 94:595-601.
32. Summers C., Rankin S.M., Condliffe A.M., Singh N., Peters A.M., Chilvers E.R. Neutrophil kinetics in health and disease. Trends Immunol. 2010, 31:318-324.
33. Cross A., Moots R.J., Edwards S.W. The dual effects of TNFalpha on neutrophil apoptosis are mediated via differential effects on expression of Mcl-1 and Bfl-1. Blood 2008, 111:878-884.
34. Derouet M., Thomas L., Cross A., Moots R.J., Edwards S.W. Granulocyte macrophage colony-stimulating factor signaling and proteasome inhibition delay neutrophil apoptosis by increasing the stability of Mcl-1. J. Biol. Chem. 2004, 279:26915-26921.
35. Akgul C., Moulding D.A., Edwards S.W. Molecular control of neutrophil apoptosis. FEBS Lett. 2001, 487:318-322.
36. Moulding D.A., Akgul C., Derouet M., White M.R., Edwards S.W. BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis. J. Leukoc. Biol. 2001, 70:783-792.
37. Thomas L.W., Lam C., Edwards S.W. Mcl-1; the molecular regulation of protein function. FEBS Lett. 2010, 584:2981-2989.
38. Witko-Sarsat V., Mocek J., Bouayad D., Tamassia N., Ribeil J.A., Candalh C., et al. Proliferating cell nuclear antigen acts as a cytoplasmic platform controlling human neutrophil survival. J. Exp. Med. 2010, 207:2631-2645.
39. Hart S.P., Ross J.A., Ross K., Haslett C., Dransfield I. Molecular characterization of the surface of apoptotic neutrophils: implications for functional downregulation and recognition by phagocytes. Cell Death Differ. 2000, 7:493-503.
40. Poon I.K., Lucas C.D., Rossi A.G., Ravichandran K.S. Apoptotic cell clearance: basic biology and therapeutic potential. Nat. Rev. Immunol. 2014, 14:166-180.
41. Midgley A., Beresford M.W. Cellular localization of nuclear antigen during neutrophil apoptosis: mechanism for autoantigen exposure. Lupus 2011, 20:641-646.
42. Bonnefoy F., Perruche S., Couturier M., Sedrati A., Sun Y., Tiberghien P., et al. Plasmacytoid dendritic cells play a major role in apoptotic leukocyte-induced immune modulation. J. Immunol. 2011, 186:5696-5705.
43. Millet A., Martin K.R., Bonnefoy F., Saas P., Mocek J., Alkan M., et al. Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis. J. Clin. Invest. 2015, 125:4107-4121.
44. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., et al. Neutrophil extracellular traps kill bacteria. Science 2004, 303:1532-1535.
45. Brinkmann V., Zychlinsky A. Neutrophil extracellular traps: is immunity the second function of chromatin. J. Cell Biol. 2012, 198:773-783.
46. Fuchs T.A., Abed U., Goosmann C., Hurwitz R., Schulze I., Wahn V., et al. Novel cell death program leads to neutrophil extracellular traps. J. Cell Biol. 2007, 176:231-241.
47. Parker H., Dragunow M., Hampton M.B., Kettle A.J., Winterbourn C.C. Requirements for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ depending on the stimulus. J. Leukoc. Biol. 2012, 92:841-849.
48. Wang Y., Li M., Stadler S., Correll S., Li P., Wang D., et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J. Cell Biol. 2009, 184:205-213.
49. Lewis H.D., Liddle J., Coote J.E., Atkinson S.J., Barker M.D., Bax B.D., et al. Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation. Nat. Chem. Biol. 2015, 11:189-191.
50. Papayannopoulos V., Metzler K.D., Hakkim A., Zychlinsky A. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J. Cell Biol. 2010, 191:677-691.
51. Takei H., Araki A., Watanabe H., Ichinose A., Sendo F. Rapid killing of human neutrophils by the potent activator phorbol 12-myristate 13-acetate (PMA) accompanied by changes different from typical apoptosis or necrosis. J. Leukoc. Biol. 1996, 59:229-240.
52. Steinberg B.E., Grinstein S. Unconventional roles of the NADPH oxidase: signaling, ion homeostasis, and cell death. Sci. STKE 2007, 2007:pe11.
53. Naccache P.H., Fernandes M.J. Challenges in the characterization of neutrophil extracellular traps: the truth is in the details. Eur. J. Immunol. 2016, 46:52-55.
54. Branzk N., Papayannopoulos V. Molecular mechanisms regulating NETosis in infection and disease. Semin. Immunopathol. 2013, 35:513-530.
55. Pilsczek F.H., Salina D., Poon K.K., Fahey C., Yipp B.G., Sibley C.D., et al. A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus. J. Immunol. 2010, 185:7413-7425.
56. Amini P., Stojkov D., Wang X., Wicki S., Kaufmann T., Wong W.W., et al. NET formation can occur independently of RIPK3 and MLKL signaling. Eur. J. Immunol. 2016, 46:178-184.
57. Desai J., Kumar S.V., Mulay S.R., Konrad L., Romoli S., Schauer C., et al. PMA and crystal-induced neutrophil extracellular trap formation involves RIPK1-RIPK3-MLKL signaling. Eur. J. Immunol. 2016, 46:223-229.
58. Parker H., Albrett A.M., Kettle A.J., Winterbourn C.C. Myeloperoxidase associated with neutrophil extracellular traps is active and mediates bacterial killing in the presence of hydrogen peroxide. J. Leukoc. Biol. 2012, 91:369-376.
59. Sorensen O.E., Clemmensen S.N., Dahl S.L., Ostergaard O., Heegaard N.H., Glenthoj A., et al. Papillon-Lefevre syndrome patient reveals species-dependent requirements for neutrophil defenses. J. Clin. Invest. 2014, 124:4539-4548.
60. Nauseef W.M. Proteases neutrophils, and periodontitis: the NET effect. J. Clin. Invest. 2014, 124:4237-4239.
61. Geering B., Stoeckle C., Conus S., Simon H.U. Living and dying for inflammation: neutrophils, eosinophils, basophils. Trends Immunol. 2013, 34:398-409.
62. Yousefi S., Mihalache C., Kozlowski E., Schmid I., Simon H.U. Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps. Cell Death Differ. 2009, 16:1438-1444.
63. Yousefi S., Simon D., Simon H.U. Eosinophil extracellular DNA traps: molecular mechanisms and potential roles in disease. Curr. Opin. Immunol. 2012, 24:736-739.
64. Yipp B.G., Kubes P. NETosis how vital is it?. Blood. 2013, 122:2784-2794.
65. Nauseef W.M. Editorial Nyet to NETs: a pause for healthy skepticism. J. Leukoc. Biol. 2012, 91:353-355.
66. Grayson P.C., Kaplan M.J. At the Bench: neutrophil extracellular traps (NETs) highlight novel aspects of innate immune system involvement in autoimmune diseases. J. Leukoc. Biol. 2016, 99:253-264.
67. Simon D., Simon H.U., Yousefi S., Extracellular D.N.A. traps in allergic, infectious, and autoimmune diseases. Allergy 2013, 68:409-416.
68. Lande R., Ganguly D., Facchinetti V., Frasca L., Conrad C., Gregorio J., et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Trans. Med. 2011, 3:73ra19.
69. Khandpur R., Carmona-Rivera C., Vivekanandan-Giri A., Gizinski A., Yalavarthi S., Knight J.S., et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci. Trans. Med. 2013, 5:178ra140.
70. Kallenberg C.G. Key advances in the clinical approach to ANCA-associated vasculitis. Nat. Rev. Rheumatol. 2014, 10:484-493.
71. Millet A., Pederzoli-Ribeil M., Guillevin L., Witko-Sarsat V., Mouthon L. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group. Ann. Rheum. Dis. 2013, 72:1273-1279.
72. Lyons P.A., Rayner T.F., Trivedi S., Holle J.U., Watts R.A., Jayne D.R., et al. Genetically distinct subsets within ANCA-associated vasculitis. New Engl. J. Med. 2012, 367:214-223.
73. Csernok E., Lamprecht P., Gross W.L. Diagnostic significance of ANCA in vasculitis. Nat. Clin. Pract. Rheumatol. 2006, 2:174-175.
74. Pendergraft WF, 3rd, Preston GA, Shah RR, Tropsha A, Carter CW, Jr., Jennette JC, et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med. 10 (2004) 10:72-79.
75. Tadema H., Kallenberg C.G., Stegeman C.A., Heeringa P. Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA-associated vasculitis. PLoS One 2011, 6:e17972.
76. Kain R., Exner M., Brandes R., Ziebermayr R., Cunningham D., Alderson C.A., et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat. Med. 2008, 14:1088-1096.
77. Kain R., Tadema H., McKinney E.F., Benharkou A., Brandes R., Peschel A., et al. High prevalence of autoantibodies to hLAMP-2 in anti-neutrophil cytoplasmic antibody-associated vasculitis. J. Am. Soc. Nephrol. 2012, 23:556-566.
78. Witko-Sarsat V., Rieu P., Descamps-Latscha B., Lesavre P., Halbwachs-Mecarelli L. Neutrophils molecules, functions and pathophysiological aspects. Lab. Invest. 2000, 80:617-653.
79. Nauseef W.M. How human neutrophils kill and degrade microbes: an integrated view. Immunol. Rev. 2007, 219:88-102.
80. Shao B., Pennathur S., Heinecke J.W. Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions. J. Biol. Chem. 2012, 287:6375-6386.
81. Bories D., Raynal M.C., Solomon D.H., Darzynkiewicz Z., Cayre Y.E. Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells. Cell 1989, 59:959-968.
82. Campanelli D., Melchior M., Fu Y., Nakata M., Shuman H., Nathan C., et al. Cloning of cDNA for proteinase 3: a serine protease, antibiotic, and autoantigen from human neutrophils. J. Exp. Med. 1990, 172:1709-1715.
83. Pham C.T. Neutrophil serine proteases: specific regulators of inflammation. Nat. Rev. Immunol. 2006, 6:541-550.
84. Hajjar E., Broemstrup T., Kantari C., Witko-Sarsat V., Reuter N. Structures of human proteinase 3 and neutrophil elastase-so similar yet so different. FEBS J. 2010, 277:2238-2254.
85. Bauer S., Abdgawad M., Gunnarsson L., Segelmark M., Tapper H., Hellmark T. Proteinase 3 and CD177 are expressed on the plasma membrane of the same subset of neutrophils. J. Leukoc. Biol. 2007, 81:458-464.
86. von Vietinghoff S., Tunnemann G., Eulenberg C., Wellner M., Cristina Cardoso M., Luft F.C., et al. NB1 mediates surface expression of the ANCA antigen proteinase 3 on human neutrophils. Blood 2007, 109:4487-4493.
87. Kantari C., Millet A., Gabillet J., Hajjar E., Broemstrup T., Pluta P., et al. Molecular analysis of the membrane insertion domain of proteinase 3, the Wegener's autoantigen, in RBL cells: implication for its pathogenic activity. J. Leukoc. Biol. 2011, 90:941-950.
88. Kantari C., Pederzoli-Ribeil M., Amir-Moazami O., Gausson-Dorey V., Moura I.C., Lecomte M.C., et al. Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis. Blood 2007, 110:4086-4095.
89. Gabillet J., Millet A., Pederzoli-Ribeil M., Tacnet-Delorme P., Guillevin L., Mouthon L., et al. Proteinase 3, the autoantigen in granulomatosis with polyangiitis, associates with calreticulin on apoptotic neutrophils, impairs macrophage phagocytosis, and promotes inflammation. J. Immunol. 2012, 189:2574-2583.
90. Scapini P., Nardelli B., Nadali G., Calzetti F., Pizzolo G., Montecucco C., et al. G-CSF-stimulated neutrophils are a prominent source of functional BLyS. J. Exp. Med. 2003, 197:297-302.
91. Scapini P., Bazzoni F., Cassatella M.A. Regulation of B-cell-activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils. Immunol. Lett. 2008, 116:1-6.
92. Holden N.J., Williams J.M., Morgan M.D., Challa A., Gordon J., Pepper R.J., et al. ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process. Ann. Rheum. Dis. 2011, 70:2229-2233.
93. Falk R.J., Terrell R.S., Charles L.A., Jennette J.C. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:4115-4119.
94. Schreiber A., Kettritz R. The neutrophil in antineutrophil cytoplasmic autoantibody-associated vasculitis. J. Leukoc. Biol. 2013, 94:623-631.
95. Xiao H., Heeringa P., Hu P., Liu Z., Zhao M., Aratani Y., et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J. Clin. Invest. 2002, 110:955-963.
96. Xiao H., Dairaghi D.J., Powers J.P., Ertl L.S., Baumgart T., Wang Y., et al. C5a receptor (CD88) blockade protects against MPO-ANCA GN. J. Am. Soc. Nephrol. 2014, 25:225-231.
97. Schreiber A., Pham C.T., Hu Y., Schneider W., Luft F.C., Kettritz R. Neutrophil serine proteases promote IL-1beta generation and injury in necrotizing crescentic glomerulonephritis. J. Am. Soc. Nephrol. 2012, 23:470-482.
98. Kessenbrock K., Krumbholz M., Schonermarck U., Back W., Gross W.L., Werb Z., et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 2009, 15:623-625.
99. Rao A.N., Kazzaz N.M., Knight J.S. Do neutrophil extracellular traps contribute to the heightened risk of thrombosis in inflammatory diseases. World J. Cardiol. 2015, 7:829-842.
100. Soehnlein O., Ortega-Gomez A., Doring Y., Weber C. Neutrophil-macrophage interplay in atherosclerosis: protease-mediated cytokine processing versus NET release. Thromb. Haemost. 2015, 114:866-867.
101. Grayson P.C., Carmona-Rivera C., Xu L., Lim N., Gao Z., Asare A.L., et al. Neutrophil-Related gene expression and low-Density granulocytes associated with disease activity and response to treatment in antineutrophil cytoplasmic antibody-Associated vasculitis. Arthritis Rheumatol. 2015, 67:1922-1932.
102. Villanueva E., Yalavarthi S., Berthier C.C., Hodgin J.B., Khandpur R., Lin A.M., et al. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J. Immunol. 2011, 187:538-552.
103. Ariel A., Serhan C.N. New lives given by cell death: macrophage differentiation following their encounter with apoptotic leukocytes during the resolution of inflammation. Front. Immunol. 2012, 3:4.
104. Csernok E., Ai M., Gross W.L., Wicklein D., Petersen A., Lindner B., et al. Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway. Blood 2006, 107:4440-4448.
105. Sangaletti S., Tripodo C., Chiodoni C., Guarnotta C., Cappetti B., Casalini P., et al. Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity. Blood 2012, 120:3007-3018.
106. Mueller A., Brieske C., Schinke S., Csernok E., Gross W.L., Hasselbacher K., et al. Plasma cells within granulomatous inflammation display signs pointing towards autoreactivity and destruction in granulomatosis with polyangiitis. Arthr. Res. Ther. 2014, 16:R55.
107. Ciavatta D.J., Yang J., Preston G.A., Badhwar A.K., Xiao H., Hewins P., et al. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis. J. Clin. Invest. 2010, 120:3209-3219.
108. Le Cabec V., Cowland J.B., Calafat J., Borregaard N. Targeting of proteins to granule subsets is determined by timing and not by sorting: the specific granule protein NGAL is localized to azurophil granules when expressed in HL-60 cells. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:6454-6457.
109. Alcorta D.A., Barnes D.A., Dooley M.A., Sullivan P., Jonas B., Liu Y., et al. Leukocyte gene expression signatures in antineutrophil cytoplasmic autoantibody and lupus glomerulonephritis. Kidney Int. 2007, 72:853-864.
110. Savage C.O., Harper L., Cockwell P., Adu D., Howie A.J. ABC of arterial and vascular disease: vasculitis. Br. Med. J. 2000, 320:1325-1328.
111. Harper L., Cockwell P., Adu D., Savage C.O. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Kidney Int. 2001, 59:1729-1738.
112. Abdgawad M., Pettersson A., Gunnarsson L., Bengtsson A.A., Geborek P., Nilsson L., et al. Decreased neutrophil apoptosis in quiescent ANCA-associated systemic vasculitis. PLoS One 2012, 7:e32439.
113. Fox S., Leitch A.E., Duffin R., Haslett C., Rossi A.G. Neutrophil apoptosis: relevance to the innate immune response and inflammatory disease. J. Innate Immun. 2010, 2:216-227.
114. Liu Z., Davidson A. Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat. Med. 2012, 18:871-882.
115. Keeling D.M., Isenberg D.A. Haematological manifestations of systemic lupus erythematosus. Blood Rev. 1993, 7:199-207.
116. Carli L., Tani C., Vagnani S., Signorini V., Mosca M. Leukopenia, lymphopenia, and neutropenia in systemic lupus erythematosus: prevalence and clinical impact-a systematic literature review. Semin. Arthr. Rheum. 2015, 45:190-194.
117. Denny M.F., Yalavarthi S., Zhao W., Thacker S.G., Anderson M., Sandy A.R., et al. A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J. Immunol. 2010, 184:3284-3297.
118. Abramson S.B., Given W.P., Edelson H.S., Weissmann G. Neutrophil aggregation induced by sera from patients with active systemic lupus erythematosus. Arthr. Rheumat. 1983, 26:630-636.
119. Courtney P.A., Crockard A.D., Williamson K., Irvine A.E., Kennedy R.J., Bell A.L. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann. Rheum. Dis. 1999, 58:309-314.
120. Bennett L., Palucka A.K., Arce E., Cantrell V., Borvak J., Banchereau J., et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 2003, 197:711-723.
121. Brandt L., Hedberg H. Impaired phagocytosis by peripheral blood granulocytes in systemic lupus erythematosus. Scand. J. Haematol. 1969, 6:348-353.
122. Cairns A.P., Crockard A.D., McConnell J.R., Courtney P.A., Bell A.L. Reduced expression of CD44 on monocytes and neutrophils in systemic lupus erythematosus: relations with apoptotic neutrophils and disease activity. Ann. Rheum. Dis. 2001, 60:950-955.
123. Donnelly S., Roake W., Brown S., Young P., Naik H., Wordsworth P., et al. Impaired recognition of apoptotic neutrophils by the C1q/calreticulin and CD91 pathway in systemic lupus erythematosus. Arthr. Rheumatol. 2006, 54:1543-1556.
124. Kaplan M.J. Neutrophils in the pathogenesis and manifestations of SLE. Nat. Rev. Rheumatol. 2011, 7:691-699.
125. Singh N., Traisak P., Martin K.A., Kaplan M.J., Cohen P.L., Denny M.F. Genomic alterations in abnormal neutrophils isolated from adult patients with systemic lupus erythematosus. Arthr. Res. Ther. 2014, 16:R165.
126. Midgley A., Beresford M.W. Increased expression of low density granulocytes in juvenile-onset systemic lupus erythematosus patients correlates with disease activity. Lupus 2015, 10.1177/0961203315608959.
127. Furebring M., Hakansson L.D., Venge P., Nilsson B., Sjolin J. Expression of the C5a receptor (CD88) on granulocytes and monocytes in patients with severe sepsis. Crit. Care 2002, 6:363-370.
128. Bengtsson A.A., Pettersson A., Wichert S., Gullstrand B., Hansson M., Hellmark T., et al. Low production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus. Arthr. Res. Ther. 2014, 16:R120.
129. Sthoeger Z.M., Bezalel S., Chapnik N., Asher I., Froy O. High alpha-defensin levels in patients with systemic lupus erythematosus. Immunology 2009, 127:116-122.
130. Vordenbaumen S., Fischer-Betz R., Timm D., Sander O., Chehab G., Richter J., et al. Elevated levels of human beta-defensin 2 and human neutrophil peptides in systemic lupus erythematosus. Lupus 2010, 19:1648-1653.
131. Brunner H.I., Mueller M., Rutherford C., Passo M.H., Witte D., Grom A., et al. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthr. Rheumatol. 2006, 54:2577-2584.
132. Lyons P.A., McKinney E.F., Rayner T.F., Hatton A., Woffendin H.B., Koukoulaki M., et al. Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis. Ann. Rheum. Dis. 2010, 69:1208-1213.
133. Hervier B., Hamidou M., Haroche J., Durant C., Mathian A., Amoura Z. Systemic lupus erythematosus associated with ANCA-associated vasculitis: an overlapping syndrome. Rheumatol. Int. 2012, 32:3285-3290.
134. Kim J.E., Park S.J., Shin J.I. The role of interleukin-17 in the associations between systemic lupus erythematosus and ANCA-associated vasculitis: comment on: systemic lupus erythematosus associated with ANCA-associated vasculitis: an overlapping syndrome?. Rheumatol. Int. 2014, 34:709-710.
135. Potter P.K., Cortes-Hernandez J., Quartier P., Botto M., Walport M.J. Lupus-prone mice have an abnormal response to thioglycolate and an impaired clearance of apoptotic cells. J. Immunol. 2003, 170:3223-3232.
136. Mossberg N., Movitz C., Hellstrand K., Bergstrom T., Nilsson S., Andersen O. Oxygen radical production in leukocytes and disease severity in multiple sclerosis. J. Neuroimmunol. 2009, 213:131-134.
137. Eksioglu-Demiralp E., Direskeneli H., Kibaroglu A., Yavuz S., Ergun T., Akoglu T. Neutrophil activation in Behcet's disease. Clin. Exp. Rheumatol. 2001, 19:S19-24.
138. Mossberg N., Andersen O., Nilsson S., Dahlgren C., Hellstrand K., Lindh M., et al. Oxygen radical production and severity of the Guillain-Barre syndrome. J. Neuroimmunol. 2007, 192:186-191.
139. Huang X., Li J., Dorta-Estremera S., Di Domizio J., Anthony S.M., Watowich S.S., et al. Neutrophils regulate humoral autoimmunity by restricting interferon-gamma production via the generation of reactive oxygen species. Cell Rep. 2015, 12:1120-1132.
140. Clark D.N., Markham J.L., Sloan C.S., Poole B.D. Cytokine inhibition as a strategy for treating systemic lupus erythematosus. Clin. Immunol. 2013, 148:335-343.
141. Zhang Z., Kyttaris V.C., Tsokos G.C. The role of IL-23/IL-17 axis in lupus nephritis. J. Immunol. 2009, 183:3160-3169.
142. Chen X.Q., Yu Y.C., Deng H.H., Sun J.Z., Dai Z., Wu Y.W., et al. Plasma IL-17A is increased in new-onset SLE patients and associated with disease activity. J. Clin. Immunol. 2010, 30:221-225.
143. Amarilyo G., Lourenco E.V., Shi F.D., La Cava A. IL-17 promotes murine lupus. J. Immunol. 2014, 193:540-543.
144. Taylor P.R., Roy S., Leal S.M., Sun Y., Howell S.J., Cobb B.A., et al. Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORgammat and dectin-2. Nat. Immunol. 2014, 15:143-151.
145. Rana A., Minz R.W., Aggarwal R., Anand S., Pasricha N., Singh S. Gene expression of cytokines (TNF-alpha, IFN-gamma), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus. Lupus 2012, 21:1105-1112.
146. Ballantine L.E., Ong J., Midgley A., Watson L., Flanagan B.F., Beresford M.W. The pro-inflammatory potential of T cells in juvenile-onset systemic lupus erythematosus. Pediatr. Rheumatol Online J. 2014, 12:4.
147. Crispin J.C., Oukka M., Bayliss G., Cohen R.A., Van Beek C.A., Stillman I.E., et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J. Immunol. 2008, 181:8761-8766.
148. Vincent F.B., Northcott M., Hoi A., Mackay F., Morand E.F. Clinical associations of serum interleukin-17 in systemic lupus erythematosus. Arthr. Res. Ther. 2013, 15:R97.
149. Wang Y., Ito S., Chino Y., Goto D., Matsumoto I., Murata H., et al. Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis. Clin. Exp. Immunol. 2010, 159:1-10.
150. Pers J.O., Daridon C., Devauchelle V., Jousse S., Saraux A., Jamin C., et al. BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann. N. Y. Acad. Sci. 2005, 1050:34-39.
151. Blanco P., Palucka A.K., Gill M., Pascual V., Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001, 294:1540-1543.
152. Bronson P.G., Chaivorapol C., Ortmann W., Behrens T.W., Graham R.R. The genetics of type I interferon in systemic lupus erythematosus. Curr. Opin. Immunol. 2012, 24:530-537.
153. Berry M.P., Graham C.M., McNab F.W., Xu Z., Bloch S.A., Oni T., et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010, 466:973-977.
154. Crow M.K., Type I. interferon in the pathogenesis of lupus. J. Immunol. 2014, 192:5459-5468.
155. Zhuang H., Han S., Xu Y., Li Y., Wang H., Yang L.J., et al. Toll-like receptor 7-stimulated tumor necrosis factor alpha causes bone marrow damage in systemic lupus erythematosus. Arthr. Rheumatol. 2014, 66:140-151.
156. Papadaki H.A., Kritikos H.D., Valatas V., Boumpas D.T., Eliopoulos G.D. Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy. Blood 2002, 100:474-482.
157. Santiago-Raber M.L., Baccala R., Haraldsson K.M., Choubey D., Stewart T.A., Kono D.H., et al. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J. Exp. Med. 2003, 197:777-788.
158. Lau C.M., Broughton C., Tabor A.S., Akira S., Flavell R.A., Mamula M.J., et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 2005, 202:1171-1177.
159. Clynes R., Dumitru C., Ravetch J.V. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 1998, 279:1052-1054.
160. Wu Y.W., Tang W., Zuo J.P. Toll-like receptors: potential targets for lupus treatment. Acta Pharmacol. Sin. 2015, 36:1395-1407.
161. Lartigue A., Colliou N., Calbo S., Francois A., Jacquot S., Arnoult C., et al. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus. J. Immunol. 2009, 183:6207-6216.
162. Patole P.S., Grone H.J., Segerer S., Ciubar R., Belemezova E., Henger A., et al. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. J. Am. Soc. Nephrol. 2005, 16:1326-1338.
163. Savarese E., Chae O.W., Trowitzsch S., Weber G., Kastner B., Akira S., et al. U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. Blood 2006, 107:3229-3234.
164. Lee P.Y., Kumagai Y., Li Y., Takeuchi O., Yoshida H., Weinstein J., et al. TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus. J. Exp. Med. 2008, 205:2995-3006.
165. Giltiay N.V., Chappell C.P., Sun X., Kolhatkar N., Teal T.H., Wiedeman A.E., et al. Overexpression of TLR7 promotes cell-intrinsic expansion and autoantibody production by transitional T1 B cells. J. Exp. Med. 2013, 210:2773-2789.
166. Vollmer J., Tluk S., Schmitz C., Hamm S., Jurk M., Forsbach A., et al. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J. Exp. Med. 2005, 202:1575-1585.
167. Stoehr A.D., Schoen C.T., Mertes M.M., Eiglmeier S., Holecska V., Lorenz A.K., et al. TLR9 in peritoneal B-1b cells is essential for production of protective self-reactive IgM to control Th17 cells and severe autoimmunity. J. Immunol. 2011, 187:2953-2965.
168. Yu P., Wellmann U., Kunder S., Quintanilla-Martinez L., Jennen L., Dear N., et al. Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE. Int. Immunol. 2006, 18:1211-1219.
169. Santiago-Raber M.L., Dunand-Sauthier I., Wu T., Li Q.Z., Uematsu S., Akira S., et al. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. J. Autoimmun. 2010, 34:339-348.
170. Lartigue A., Courville P., Auquit I., Francois A., Arnoult C., Tron F., et al. Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus. J. Immunol. 2006, 177:1349-1354.
171. Christensen S.R., Shupe J., Nickerson K., Kashgarian M., Flavell R.A., Shlomchik M.J. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 2006, 25:417-428.
172. Desnues B., Macedo A.B., Roussel-Queval A., Bonnardel J., Henri S., Demaria O., et al. TLR8 on dendritic cells and TLR9 on B cells restrain TLR7-mediated spontaneous autoimmunity in C57BL/6 mice. Proc. Natl. Acad. Sci. 2014, 111:1497-1502.
173. Sadanaga A., Nakashima H., Akahoshi M., Masutani K., Miyake K., Igawa T., et al. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice. Arthr. Rheumatol. 2007, 56:1618-1628.
174. Teichmann L.L., Schenten D., Medzhitov R., Kashgarian M., Shlomchik M.J. Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus. Immunity 2013, 38:528-540.
175. Huebener P., Pradere J.P., Hernandez C., Gwak G.Y., Caviglia J.M., Mu X., et al. The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis. J. Clin. Invest. 2015, 125:539-550.
176. Garcia-Romo G.S., Caielli S., Vega B., Connolly J., Allantaz F., Xu Z., et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Trans. Med. 2011, 3:73ra20.
177. Kahlenberg J.M., Carmona-Rivera C., Smith C.K., Kaplan M.J. Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages. J. Immunol. 2013, 190:1217-1226.
178. Nickerson K.M., Cullen J.L., Kashgarian M., Shlomchik M.J. Exacerbated autoimmunity in the absence of TLR9 in MRL. Fas(lpr) mice depends on Ifnar1. J. Immunol. 2013, 190:3889-3894.
179. Nickerson K.M., Christensen S.R., Cullen J.L., Meng W., Luning Prak E.T., Shlomchik M.J. TLR9 promotes tolerance by restricting survival of anergic anti-DNA B cells, yet is also required for their activation. J. Immunol. 2013, 190:1447-1456.
180. Nundel K., Green N.M., Shaffer A.L., Moody K.L., Busto P., Eilat D., et al. Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses. J. Immunol. 2015, 194:2504-2512.
181. Pawaria S., Moody K.L., Busto P., Nundel K., Baum R., Sharma S., et al. An unexpected role for RNA-sensing toll-like receptors in a murine model of DNA accrual. Clin. Exp. Rheumatol. 2015, 33:S70-73.
182. Hakkim A., Furnrohr B.G., Amann K., Laube B., Abed U.A., Brinkmann V., et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:9813-9818.
183. Campbell A.M., Kashgarian M., Shlomchik M.J. NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus. Sci. Transl. Med. 2012, 4:157ra141.
184. Knight J.S., Zhao W., Luo W., Subramanian V., O'Dell A.A., Yalavarthi S., et al. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. J. Clin. Invest. 2013, 123:2981-2993.
185. Lood C., Blanco L.P., Purmalek M.M., Carmona-Rivera C., De Ravin S.S., Smith C.K., et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat. Med. 2016, 22:146-153.
186. McInnes I.B., Schett G. The pathogenesis of rheumatoid arthritis. New Engl. J. Med. 2011, 365:2205-2219.
187. Skeoch S. Bruce IN. Atherosclerosis in rheumatoid arthritis: is it all about inflammation. Nat. Rev. Rheumatol. 2015, 11:390-400.
188. Artifoni M., Rothschild P.R., Brezin A., Guillevin L., Puechal X. Ocular inflammatory diseases associated with rheumatoid arthritis. Nat. Rev. Rheumatol. 2014, 10:108-116.
189. Robinson J., Watson F., Bucknall R.C., Edwards S.W. Activation of neutrophil reactive-oxidant production by synovial fluid from patients with inflammatory joint disease. Soluble and insoluble immunoglobulin aggregates activate different pathways in primed and unprimed cells. Biochem. J 1992, 286:345-351.
190. Sopata I., Wize J., Filipowicz-Sosnowska A., Stanislawska-Biernat E., Brzezinska B., Maslinski S. Neutrophil gelatinase levels in plasma and synovial fluid of patients with rheumatic diseases. Rheumatol. Int. 1995, 15:9-14.
191. Wong S.H., Francis N., Chahal H., Raza K., Salmon M., Scheel-Toellner D., et al. Lactoferrin is a survival factor for neutrophils in rheumatoid synovial fluid. Rheumatology 2009, 48:39-44.
192. Momohara S., Kashiwazaki S., Inoue K., Saito S., Nakagawa T. Elastase from polymorphonuclear leukocyte in articular cartilage and synovial fluids of patients with rheumatoid arthritis. Clin. Rheumatol. 1997, 16:133-140.
193. Nzeusseu Toukap A., Delporte C., Noyon C., Franck T., Rousseau A., Serteyn D., et al. Myeloperoxidase and its products in synovial fluid of patients with treated or untreated rheumatoid arthritis. Free Radic. Res. 2014, 48:461-465.
194. Katano M., Okamoto K., Arito M., Kawakami Y., Kurokawa M.S., Suematsu N., et al. Implication of granulocyte-macrophage colony-stimulating factor induced neutrophil gelatinase-associated lipocalin in pathogenesis of rheumatoid arthritis revealed by proteome analysis. Arthr. Res. Ther. 2009, 11:R3.
195. Baici A., Salgam P., Cohen G., Fehr K., Boni A. Action of collagenase and elastase from human polymorphonuclear leukocytes on human articular cartilage. Rheumatol. Int. 1982, 2:11-16.
196. Van den Steen P.E., Proost P., Grillet B., Brand D.D., Kang A.H., Van Damme J., et al. Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J. 2002, 16:379-389.
197. Elsaid K.A., Jay G.D., Chichester C.O. Detection of collagen type II and proteoglycans in the synovial fluids of patients diagnosed with non-infectious knee joint synovitis indicates early damage to the articular cartilage matrix Osteoarthritis and cartilage/OARS. Osteoarthr. Res. Soc. 2003, 11:673-680.
198. Lefrancais E., Roga S., Gautier V., Gonzalez-de-Peredo A., Monsarrat B., Girard J.P., et al. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc. Natl. Acad. Sci. 2012, 109:1673-1678.
199. Hurst S.M., Wilkinson T.S., McLoughlin R.M., Jones S., Horiuchi S., Yamamoto N., et al. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 2001, 14:705-714.
200. Miyata J., Tani K., Sato K., Otsuka S., Urata T., Lkhagvaa B., et al.Cathepsin G. the significance in rheumatoid arthritis as a monocyte chemoattractant. Rheumatol. Int. 2007, 27:375-382.
201. Oseas R., Yang H.H., Baehner R.L., Boxer L.A. Lactoferrin a promoter of polymorphonuclear leukocyte adhesiveness. Blood 1981, 57:939-945.
202. Assi L.K., Wong S.H., Ludwig A., Raza K., Gordon C., Salmon M., et al. Tumor necrosis factor alpha activates release of B lymphocyte stimulator by neutrophils infiltrating the rheumatoid joint. Arthr. Rheumatol. 2007, 56:1776-1786.
203. Chakravarti A., Raquil M.A., Tessier P., Poubelle P.E. R.A.N.K.L. surface of Toll-like receptor 4-stimulated human neutrophils activates osteoclastic bone resorption. Blood 2009, 114:1633-1644.
204. Wright H.L., Chikura B., Bucknall R.C., Moots R.J., Edwards S.W. Changes in expression of membrane TNF, NF-{kappa}B activation and neutrophil apoptosis during active and resolved inflammation. Ann. Rheum. Dis. 2011, 70:537-543.
205. Cross A., Edwards S.W., Bucknall R.C., Moots R.J. Secretion of oncostatin M by neutrophils in rheumatoid arthritis. Arthr. Rheumatol. 2004, 50:1430-1436.
206. Pelletier M., Maggi L., Micheletti A., Lazzeri E., Tamassia N., Costantini C., et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 2010, 115:335-343.
207. Cross A., Bucknall R.C., Cassatella M.A., Edwards S.W., Moots R.J. Synovial fluid neutrophils transcribe and express class II major histocompatibility complex molecules in rheumatoid arthritis. Arthr. Rheumatol. 2003, 48:2796-2806.
208. Parsonage G., Filer A., Bik M., Hardie D., Lax S., Howlett K., et al. Prolonged, granulocyte-macrophage colony-stimulating factor-dependent, neutrophil survival following rheumatoid synovial fibroblast activation by IL-17 and TNFalpha. Arthr. Res. Ther. 2008, 10:R47-59.
209. Cross A., Barnes T., Bucknall R.C., Edwards S.W., Moots R.J. Neutrophil apoptosis in rheumatoid arthritis is regulated by local oxygen tensions within joints. J. Leukoc. Biol. 2006, 80:521-528.
210. Raza K., Scheel-Toellner D., Lee C.Y., Pilling D., Curnow S.J., Falciani F., et al. Synovial fluid leukocyte apoptosis is inhibited in patients with very early rheumatoid arthritis. Arthr. Res. Ther. 2006, 8:R120-127.
211. Weinmann P., Moura R.A., Caetano-Lopes J.R., Pereira P.A., Canhao H., Queiroz M.V., et al. Delayed neutrophil apoptosis in very early rheumatoid arthritis patients is abrogated by methotrexate therapy. Clin. Exp. Rheumatol. 2007, 25:885-887.
212. Turrel-Davin F., Tournadre A., Pachot A., Arnaud B., Cazalis M.A., Mougin B., et al. FoxO3a involved in neutrophil and T cell survival is overexpressed in rheumatoid blood and synovial tissue. Ann. Rheumic Dis. 2010, 69:755-760.
213. Talbot J., Bianchini F.J., Nascimento D.C., Oliveira R.D., Souto F.O., Pinto L.G., et al. CCR2 expression in neutrophils plays a critical role in their migration into the joints in rheumatoid arthritis. Arthr. Rheumatol. 2015, 67:1751-1759.
214. de Siqueira M.B., da Mota L.M., Couto S.C., Muniz-Junqueira M.I. Enhanced neutrophil phagocytic capacity in rheumatoid arthritis related to the autoantibodies rheumatoid factor and anti-cyclic citrullinated peptides. BMC Musculoskelet Disord. 2015, 16:159.
215. Rollet-Labelle E., Vaillancourt M., Marois L., Newkirk M.M., Poubelle P.E., Naccache P.H. Cross-linking of IgGs bound on circulating neutrophils leads to an activation of endothelial cells: possible role of rheumatoid factors in rheumatoid arthritis-associated vascular dysfunction. J. Inflamm. 2013, 10:27.
216. Watson F., Robinson J.J., Phelan M., Bucknall R.C., Edwards S.W. Receptor expression in synovial fluid neutrophils from patients with rheumatoid arthritis. Ann. Rheum. Dis. 1993, 52:354-359.
217. Quayle J.A., Watson F., Bucknall R.C., Edwards S.W. Neutrophils from the synovial fluid of patients with rheumatoid arthritis express the high affinity immunoglobulin G receptor, Fc gamma RI (CD64): role of immune complexes and cytokines in induction of receptor expression. Immunology 1997, 91:266-273.
218. Eggleton P., Wang L., Penhallow J., Crawford N., Brown K.A. Differences in oxidative response of subpopulations of neutrophils from healthy subjects and patients with rheumatoid arthritis. Ann. Rheum. Dis. 1995, 54:916-923.
219. Dang P.M., Stensballe A., Boussetta T., Raad H., Dewas C., Kroviarski Y., et al. A specific p47phox -serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites. J. Clin. Invest. 2006, 116:2033-2043.
220. Wang W., Jian Z., Guo J., Ning X. Increased levels of serum myeloperoxidase in patients with active rheumatoid arthritis. Life Sci. 2014, 117:19-23.
221. Stamp L.K., Khalilova I., Tarr J.M., Senthilmohan R., Turner R., Haigh R.C., et al. Myeloperoxidase and oxidative stress in rheumatoid arthritis. Rheumatology 2012, 51:1796-1803.
222. Datta S., Kundu S., Ghosh P., De S., Ghosh A., Chatterjee M. Correlation of oxidant status with oxidative tissue damage in patients with rheumatoid arthritis. Clin. Rheumatol. 2014, 33:1557-1564.
223. Cross A., Bakstad D., Allen J.C., Thomas L., Moots R.J., Edwards S.W. Neutrophil gene expression in rheumatoid arthritis. Pathophysiology 2005, 12:191-202.
224. Wright H.L., Thomas H.B., Moots R.J., Edwards S.W. Interferon gene expression signature in rheumatoid arthritis neutrophils correlates with a good response to TNFi therapy. Rheumatology 2015, 54:188-193.
225. Wittkowski H., Foell D., af Klint E., De Rycke L., De Keyser F., Frosch M., et al. Effects of intra-articular corticosteroids and anti-TNF therapy on neutrophil activation in rheumatoid arthritis. Ann. Rheum. Dis. 2007, 66:1020-1025.
226. Nordal H.H., Brun J.G., Halse A.K., Jonsson R., Fagerhol M.K., Hammer H.B. The neutrophil protein S100A12 is associated with a comprehensive ultrasonographic synovitis score in a longitudinal study of patients with rheumatoid arthritis treated with adalimumab. BMC Musculoskelet. Disord. 2014, 15:335.
227. Matsumoto T., Kaneko T., Seto M., Wada H., Kobayashi T., Nakatani K., et al. The membrane proteinase 3 expression on neutrophils was downregulated after treatment with infliximab in patients with rheumatoid arthritis. Clin. Appl. Thrombosis/Hemostasis. 2008, 14:186-192.
228. Dominical V.M., Bertolo M.B., Almeida C.B., Garrido V.T., Miguel L.I., Costa F.F., et al. Neutrophils of rheumatoid arthritis patients on anti-TNF-alpha therapy and in disease remission present reduced adhesive functions in association with decreased circulating neutrophil-attractant chemokine levels. Scand. J. Immunol. 2011, 73:309-318.
229. Scally S.W., Petersen J., Law S.C., Dudek N.L., Nel H.J., Loh K.L., et al. A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. J. Exp. Med. 2013, 210:2569-2582.
230. Sur Chowdhury C., Giaglis S., Walker U.A., Buser A., Hahn S., Hasler P. Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility. Arthr. Res. Ther. 2014, 16:R122.
231. Pratesi F., Dioni I., Tommasi C., Alcaro M.C., Paolini I., Barbetti F., et al. Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps. Ann. Rheum. Dis. 2013, 73:1414-1422.
232. Romero V., Fert-Bober J., Nigrovic P.A., Darrah E., Haque U.J., Lee D.M., et al. Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis. Sci. Trans. Med. 2013, 5:209ra150.
233. Corsiero E., Bombardieri M., Carlotti E., Pratesi F., Robinson W., Migliorini P., et al. Single cell cloning and recombinant monoclonal antibodies generation from RA synovial B cells reveal frequent targeting of citrullinated histones of NETs. Ann. Rheum. Dis. 2015.
234. Hoffmann M.H., Bruns H., Backdahl L., Neregard P., Niederreiter B., Herrmann M., et al. The cathelicidins LL-37 and rCRAMP are associated with pathogenic events of arthritis in humans and rats. Ann. Rheum. Dis. 2013, 72:1239-1248.
235. Viatte S., Plant D., Raychaudhuri S. Genetics and epigenetics of rheumatoid arthritis. Nat. Rev. Rheumatol. 2013, 9:141-153.
236. Chang H.H., Dwivedi N., Nicholas A.P., Ho I.C. The W620 polymorphism in PTPN22 disrupts its interaction with peptidylarginine deiminase type 4 and enhances citrullination and NETosis. Arthr. Rheumatol. 2015, 67:2323-2334.
237. Bayley R., Kite K.A., McGettrick H.M., Smith J.P., Kitas G.D., Buckley C.D., et al. The autoimmune-associated genetic variant PTPN22 R620W enhances neutrophil activation and function in patients with rheumatoid arthritis and healthy individuals. Ann. Rheum. Dis. 2015, 74:1588-1595.
238. Wipke B.T., Allen P.M. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J. Immunol. 2001, 167:1601-1608.
239. Elliott E.R., Van Ziffle J.A., Scapini P., Sullivan B.M., Locksley R.M., Lowell C.A. Deletion of Syk in neutrophils prevents immune complex arthritis. J. Immunol. 2011, 187:4319-4330.
240. Rohrbach A.S., Hemmers S., Arandjelovic S., Corr M., Mowen K.A. PAD4 is not essential for disease in the K/BxN murine autoantibody-mediated model of arthritis. Arthr. Res. Ther. 2012, 14:R104.
241. Seri Y., Shoda H., Suzuki A., Matsumoto I., Sumida T., Fujio K., et al. Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate isomerase-induced arthritis model. Sci. Rep. 2015, 5:13041.
242. Headland S.E., Jones H.R., Norling L.V., Kim A., Souza P.R., Corsiero E., et al. Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis. Sci. Trans. Med. 2015, 7:315ra190.
243. Zhang C., Li Y., Tang W., Kamiya N., Kim H. Lactoferrin activates BMP7 gene expression through the mitogen-activated protein kinase ERK pathway in articular cartilage. Biochem. Biophys. Res. Commun. 2013, 431:31-35.
244. Lin Y.T., Wang C.T., Gershwin M.E., Chiang B.L. The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis. Autoimmun. Rev. 2011, 10:482-489.
245. Jarvis J.N., Jiang K., Petty H.R., Neutrophils Centola M. the forgotten cell in JIA disease pathogenesis. Pediatr. Rheumatol. Online J. 2007, 5:13.
246. Bruck N., Schnabel A., Hedrich C.M. Current understanding of the pathophysiology of systemic juvenile idiopathic arthritis (sJIA) and target-directed therapeutic approaches. Clin. Immunol. 2015, 159:72-83.
247. Jarvis J.N., Petty H.R., Tang Y., Frank M.B., Tessier P.A., Dozmorov I., et al. Evidence for chronic, peripheral activation of neutrophils in polyarticular juvenile rheumatoid arthritis. Arthr. Res. Ther. 2006, 8:R154.
248. Jarvis J.N., Jiang K., Frank M.B., Knowlton N., Aggarwal A., Wallace C.A., et al. Gene expression profiling in neutrophils from children with polyarticular juvenile idiopathic arthritis. Arthr. Rheumatol. 2009, 60:1488-1495.